GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,049.00
+9.00 (0.87%)
Mar 10, 2026, 9:09 AM KST

GeneOne Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
88,608168,840222,271553,6511,250,928961,062
Upgrade
Market Cap Growth
-47.64%-24.04%-59.85%-55.74%30.16%1733.31%
Upgrade
Enterprise Value
116,286188,532219,584509,9451,241,186881,347
Upgrade
Last Close Price
1040.002115.002840.007140.0016200.0013850.76
Upgrade
PS Ratio
2.874.735.5311.3632.3223.16
Upgrade
PB Ratio
1.601.971.993.056.069.76
Upgrade
P/TBV Ratio
1.611.982.003.066.089.82
Upgrade
EV/Sales Ratio
3.765.285.4610.4732.0721.24
Upgrade
Debt / Equity Ratio
0.550.320.150.110.090.18
Upgrade
Net Debt / Equity Ratio
0.500.300.06-0.14-0.43-0.74
Upgrade
Net Debt / EBITDA Ratio
-1.23-1.01-0.200.753.895.01
Upgrade
Net Debt / FCF Ratio
-1.62-1.31-0.260.371.022.27
Upgrade
Asset Turnover
0.230.240.220.210.200.44
Upgrade
Inventory Turnover
2.762.973.233.103.173.55
Upgrade
Quick Ratio
0.140.240.771.663.362.68
Upgrade
Current Ratio
0.500.671.512.163.872.96
Upgrade
Return on Equity (ROE)
-71.52%-49.25%-53.09%-19.67%-10.42%-30.43%
Upgrade
Return on Assets (ROA)
-19.32%-17.79%-16.17%-10.61%-8.88%-12.34%
Upgrade
Return on Capital Employed (ROCE)
-52.60%-39.50%-37.70%-21.30%-12.70%-18.60%
Upgrade
Earnings Yield
-57.97%-28.75%-34.99%-6.89%-1.27%-1.94%
Upgrade
FCF Yield
-19.32%-11.46%-12.30%-12.54%-6.98%-3.34%
Upgrade
Buyback Yield / Dilution
-3.63%-2.20%-0.34%-4.37%-22.98%-88.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.